Flow cytometry‐based detection of functional CCR5 variants: A scalable screening approach for HIV ‐resistant cord blood stem cells
Transfusion · 2026-06 · 66 (6) · 1151-1159
DOI: 10.1111/trf.70218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 08.04.2026. Verfasst von Carl Simard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Héma-Québec, Medical Affairs and Innovation, Québec City, Québec, Canada. Hauptthemen laut MEDLINE: Receptors, CCR5, Flow Cytometry, Fetal Blood, HIV Infections. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Allogeneic hematopoietic stem cell transplantation can achieve durable HIV remission when donor cells exhibit reduced or absent C‐C chemokine receptor type 5 (CCR5) function, but CCR5Δ32/Δ32 donors are rare and cord blood banks (CBBs) do not routinely screen inventories for CCR5‐deficient units. We evaluated a scalable flow cytometry–based phenotyping strategy to identify cord blood units (CBUs) with intrinsically reduced CCR5 surface expression and to determine whether low‐expression phenotypes enrich for CCR5Δ32 and other CCR5 variants. Study Design and Methods CCR5 (CD195) surface expression was quantified by flow cytometry on viable IFN‐γ‐stimulated CD14 + monocytes. Values were batch‐normalized ( Z ‐score), and low expressors were defined as Z < −1. Low CBUs were genotyped for CCR5Δ32 by polymerase chain reaction (PCR), and Δ32‐negative CBUs underwent targeted sequencing of the CCR5 promoter and coding exons.
Results
Of 179 CBUs, 27 (15.1%) were classified as Low CCR5 expressors. Batch‐normalized CCR5 mean fluorescence intensity discriminated low from high phenotypes with high accuracy (area under the curve 0.9058; 95% confidence interval [CI] 0.8490–0.9626; p < 0.0001). Assay repeatability showed intra‐day coefficient of variation (CV) 7.00% and inter‐day CV 13.65%. Among low CBUs ( n = 27), PCR identified 12 wild‐type/Δ32 and 3 Δ32/Δ32 genotypes, while 12 (44.4%) were non‐Δ32. Sequencing of non‐Δ32 low CBUs revealed multiple distinct genotypes, indicating genetic heterogeneity underlying reduced CCR5 expression.
Conclusion
A standardized, batch‐normalized flow cytometry assay enables practical phenotypic screening of CBB inventories for reduced CCR5 expression and enriches for both CCR5Δ32 and diverse non‐Δ32 variants. This phenotype‐first strategy may complement targeted genotyping by identifying candidate HIV‐resistant CBUs missed by Δ32‐focused approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Héma-Québec, Medical Affairs and Innovation, Québec City, Québec, Canada.
- Héma-Québec Cord Blood Bank, Montréal, Québec, Canada.
- Université Laval, Département de Microbiologie-Infectiologie et Immunologie, Québec City, Québec, Canada.
ORCID-Profile: Carl Simard, Patrick Trépanier
Zitieren
APA
Simard, C., Perreault, J., Fournier, D., & Trépanier, P. (2026). Flow cytometry‐based detection of functional CCR5 variants: A scalable screening approach for HIV ‐resistant cord blood stem cells. Transfusion, 66(6), 1151-1159. https://doi.org/10.1111/trf.70218
Vancouver
Simard C, Perreault J, Fournier D, Trépanier P. Flow cytometry‐based detection of functional CCR5 variants: A scalable screening approach for HIV ‐resistant cord blood stem cells. Transfusion. 2026;66(6):1151-1159. doi:10.1111/trf.70218
BibTeX
@article{Simard2026,
author = {Simard, Carl and Perreault, Josée and Fournier, Diane and Trépanier, Patrick},
title = {Flow cytometry‐based detection of functional CCR5 variants: A scalable screening approach for HIV ‐resistant cord blood stem cells},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {6},
pages = {1151--1159},
doi = {10.1111/trf.70218}
}
EUVIMED